Maxim Group Lowers HCW Biologics (NASDAQ:HCWB) Price Target to $35.00
HCW Biologics (NASDAQ:HCWB – Get Free Report) had its price objective lowered by research analysts at Maxim Group from $120.00 to $35.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Maxim Group’s price target would indicate a potential upside of 343.04% from the stock’s previous close. […]
HCW Biologics (NASDAQ:HCWB – Get Free Report) had its price objective lowered by research analysts at Maxim Group from $120.00 to $35.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Maxim Group’s price target would indicate a potential upside of 343.04% from the stock’s previous close. […]
